维奈普拉萨德博士在FDA政策的持续争议中重返工作. Dr. Vinay Prasad returns to the FDA amid ongoing controversy over the agency’s policies.

美国食品和药品管理局(FDA)政策的批评家Vinay Prasad博士在短暂辞职后又回到了该机构的岗位。 Dr. Vinay Prasad, a critic of the U.S. Food and Drug Administration's (FDA) policies, has returned to his position at the agency after a brief resignation. 他于7月下旬首次离开是因为右翼活动家劳拉·劳默施压,以及对他先前对林业发展局药品批准和COVID-19疫苗政策的批评进行仔细审查。 His initial departure in late July was due to pressure from right-wing activist Laura Loomer and scrutiny over his previous criticisms of the FDA's drug approvals and COVID-19 vaccine policies. 尽管Loomer声称他是一个“渐进的左翼破坏者”, Prasad的复职表明他继续得到林业发展局内部的支持。 Despite Loomer's claims that he was a "progressive leftist saboteur," Prasad's reinstatement suggests continued support from within the FDA. 他回国时, 机构处理基因疗法审批事宜时, 出现争议。 His return comes amid controversy over the agency’s handling of gene therapy approvals.